1. De Broe ME, Elseviers MM. Analgesic nephropathy. N Engl J Med 1998;338:446–452. PMID:
9459649.
2. Chang SH, Mathew TH, McDonald SP. Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes. Clin J Am Soc Nephrol 2008;3:768–776. PMID:
18272825.
3. Buckalew VM Jr, Schey HM. Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence. Medicine (Baltimore) 1986;65:291–303. PMID:
3489155.
4. De Broe ME, Elseviers MM. Over-the-counter analgesic use. J Am Soc Nephrol 2009;20:2098–2103. PMID:
19423685.
5. Pinter I, Matyus J, Czegany Z, Harsanyi J, Homoki M, Kassai M, et al. Analgesic nephropathy in Hungary: the HANS study. Nephrol Dial Transplant 2004;19:840–843. PMID:
15031338.
6. Bennett WM, DeBroe ME. Analgesic nephropathy: a preventable renal disease. N Engl J Med 1989;320:1269–1271. PMID:
2710205.
7. Delzell E, Shapiro S. A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease. Medicine (Baltimore) 1998;77:102–121. PMID:
9556702.
8. Dubach UC, Rosner B, Sturmer T. An epidemiologic study of abuse of analgesic drugs: effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987). N Engl J Med 1991;324:155–160. PMID:
1984193.
9. Mihatsch MJ, Khanlari B, Brunner FP. Obituary to analgesic nephropathy: an autopsy study. Nephrol Dial Transplant 2006;21:3139–3145. PMID:
16891638.
10. Noels LM, Elseviers MM, de Broe ME. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium. Nephrol Dial Transplant 1995;10:167–174. PMID:
7753450.
11. Brunner FP, Selwood NH. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee. Nephrol Dial Transplant 1994;9:1371–1376. PMID:
7816247.
12. Gault MH, Wilson DR. Analgesic nephropathy in Canada: clinical syndrome, management, and outcome. Kidney Int 1978;13:58–63. PMID:
713269.
13. Mabeck CE, Wichmann B. Mortality from chronic interstitial nephritis and phenacetin consumption in Denmark. Acta Med Scand 1979;205:599–601. PMID:
474188.
14. Nanra RS. Analgesic nephropathy in the 1990s: an Australian perspective. Kidney Int Suppl 1993;42:S86–S92. PMID:
8361137.
15. Wilson DR, Gault MH. Declining incidence of analgesic nephropathy in Canada. Can Med Assoc J 1982;127:500–502. PMID:
7116267.
16. Michielsen P, de Schepper P. Trends of analgesic nephropathy in two high-endemic regions with different legislation. J Am Soc Nephrol 2001;12:550–556. PMID:
11181803.
17. Kincaid-Smith P. Analgesic nephropathy. Kidney Int 1978;13:1–4. PMID:
713262.
18. Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin: renal morbidity and mortality (1968-1979). N Engl J Med 1983;308:357–362. PMID:
6823240.
19. McCredie M, Stewart JH, Mathew TH, Disney AP, Ford JM. The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure. Clin Nephrol 1989;31:35–39. PMID:
2783667.
20. Pan Y, Zhang L, Wang F, Li X, Wang H. China National Survey of Chronic Kidney Disease Working Group. Status of non-steroidal anti-inflammatory drugs use and its association with chronic kidney disease: a cross-sectional survey in China. Nephrology (Carlton) 2014;19:655–660. PMID:
25196389.
21. Prescott LF. Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs 1982;23:75–149. PMID:
7035123.
22. Stewart JH, Gallery ED. Analgesic abuse and kidney disease. Aust N Z J Med 1976;6:498–508. PMID:
1071883.
23. Henrich WL. Analgesic nephropathy. Am J Med Sci 1988;295:561–568. PMID:
3291614.
24. Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 2004;164:1519–1524. PMID:
15277282.
25. Sandler DP, Smith JC, Weinberg CR, Buckalew VM Jr, Dennis VW, Blythe WB, et al. Analgesic use and chronic renal disease. N Engl J Med 1989;320:1238–1243. PMID:
2651928.
26. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675–1679. PMID:
7969358.
27. Steenland NK, Thun MJ, Ferguson CW, Port FK. Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health 1990;80:153–157. PMID:
2153349.
28. Kelkar M, Cleves MA, Foster HR, Hogan WR, James LP, Martin BC. Acute and chronic acetaminophen use and renal disease: a case-control study using pharmacy and medical claims. J Manag Care Pharm 2012;18:234–246. PMID:
22468732.
29. Agodoa LY, Francis ME, Eggers PW. Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults. Am J Kidney Dis 2008;51:573–583. PMID:
18371533.
30. Ferguson I, Johnson F, Reay B, Wigley R. Aspirin, phenacetin, and the kidney: a rheumatism clinic study. Med J Aust 1977;1:950–954. PMID:
887037.
31. Caughey DE, Isdale IC, Tweed JM, Treadwell BL, Laing JK, Kirk J, et al. Aspirin and the kidney. New Zealand Rheumatism Association Study. Br Med J 1974;1:593–596. PMID:
4821007.
32. Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM. Analgesic use and renal function in men. JAMA 2001;286:315–321. PMID:
11466097.
33. Okada S, Morimoto T, Ogawa H, Sakuma M, Soejima H, Nakayama M, et al. Is long-term low-dose aspirin therapy associated with renal dysfunction in patients with type 2 diabetes? JPAD2 Cohort Study. PLoS One 2016;11:e0147635PMID:
26808136.
34. Ibanez L, Morlans M, Vidal X, Martinez MJ, Laporte JR. Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. Kidney Int 2005;67:2393–2398. PMID:
15882284.
35. Macklon AF, Craft AW, Thompson M, Kerr DN. Aspirin and analgesic nephropathy. Br Med J 1974;1:597–600. PMID:
4821008.
36. Emkey RD, Mills JA. Aspirin and analgesic nephropathy. JAMA 1982;247:55–57. PMID:
7053442.
37. Elseviers MM, De Broe ME. A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int 1995;48:1912–1919. PMID:
8587252.
38. Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001;345:1801–1808. PMID:
11752356.
39. Ingrasciotta Y, Sultana J, Giorgianni F, Fontana A, Santangelo A, Tari DU, et al. Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study. PLoS One 2015;10:e0122899PMID:
25880729.
41. Michielsen P, Heinemann L, Mihatsch M, Schnulle P, Graf H, Koch KM. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study. Nephrol Dial Transplant 2009;24:1253–1259. PMID:
19037086.
42. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991;115:165–172. PMID:
2058870.
43. Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, et al. NSAID use and progression of chronic kidney disease. Am J Med 2007;120:280.e1–280.e7.
44. Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review. Fam Pract 2013;30:247–255. PMID:
23302818.
45. Josephy D, Mannervik B. Molecular toxicology. 2nd ed. Oxford: Oxford University Press. 2006.
46. Lanes SF, Delzell E, Dreyer NA, Rothman KJ. Analgesics and kidney disease. Int J Epidemiol 1986;15:454–455. PMID:
3818151.
47. Henrich WL, Agodoa LE, Barrett B, Bennett WM, Blantz RC, Buckalew VM Jr, et al. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis 1996;27:162–165. PMID:
8546133.
48. Feinstein AR, Heinemann LA, Curhan GC, Delzell E, Deschepper PJ, Fox JM, et al. Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int 2000;58:2259–2264. PMID:
11115060.